Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Overuse or underuse of methylphenidate in adults in France: commentary on Pauly et al. 2018.

Weibel S, Lopez R, Micoulaud-Franchi JA, Bioulac S, Lecendreux M, Bertschy G.

Br J Clin Pharmacol. 2019 Jan;85(1):273-274. doi: 10.1111/bcp.13758. Epub 2018 Sep 25. No abstract available.

PMID:
30255566
2.

Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.

Plazzi G, Ruoff C, Lecendreux M, Dauvilliers Y, Rosen CL, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.

Lancet Child Adolesc Health. 2018 Jul;2(7):483-494. doi: 10.1016/S2352-4642(18)30133-0. Epub 2018 May 21.

PMID:
30169321
3.

Lauflumide (NLS-4) Is a New Potent Wake-Promoting Compound.

Luca G, Bandarabadi M, Konofal E, Lecendreux M, Ferrié L, Figadère B, Tafti M.

Front Neurosci. 2018 Aug 15;12:519. doi: 10.3389/fnins.2018.00519. eCollection 2018.

4.

Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning.

Zhang Z, Mayer G, Dauvilliers Y, Plazzi G, Pizza F, Fronczek R, Santamaria J, Partinen M, Overeem S, Peraita-Adrados R, da Silva AM, Sonka K, Rio-Villegas RD, Heinzer R, Wierzbicka A, Young P, Högl B, Bassetti CL, Manconi M, Feketeova E, Mathis J, Paiva T, Canellas F, Lecendreux M, Baumann CR, Barateau L, Pesenti C, Antelmi E, Gaig C, Iranzo A, Lillo-Triguero L, Medrano-Martínez P, Haba-Rubio J, Gorban C, Luca G, Lammers GJ, Khatami R.

Sci Rep. 2018 Jul 13;8(1):10628. doi: 10.1038/s41598-018-28840-w.

5.

Kleine-Levin syndrome is associated with LMOD3 variants.

Al Shareef SM, Basit S, Li S, Pfister C, Pradervand S, Lecendreux M, Mayer G, Dauvilliers Y, Salpietro V, Houlden H, BaHammam AS, Tafti M.

J Sleep Res. 2018 Jun 19:e12718. doi: 10.1111/jsr.12718. [Epub ahead of print]

PMID:
29923248
6.

Emerging psychiatric disorders in Kleine-Levin syndrome.

Groos E, Chaumereuil C, Flamand M, Brion A, Bourdin H, Slimani V, Lecendreux M, Arnulf I.

J Sleep Res. 2018 Oct;27(5):e12690. doi: 10.1111/jsr.12690. Epub 2018 Apr 14.

PMID:
29655261
7.

Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder.

Daley D, Van Der Oord S, Ferrin M, Cortese S, Danckaerts M, Doepfner M, Van den Hoofdakker BJ, Coghill D, Thompson M, Asherson P, Banaschewski T, Brandeis D, Buitelaar J, Dittmann RW, Hollis C, Holtmann M, Konofal E, Lecendreux M, Rothenberger A, Santosh P, Simonoff E, Soutullo C, Steinhausen HC, Stringaris A, Taylor E, Wong ICK, Zuddas A, Sonuga-Barke EJ.

J Child Psychol Psychiatry. 2018 Sep;59(9):932-947. doi: 10.1111/jcpp.12825. Epub 2017 Oct 30. Review.

PMID:
29083042
8.

The clinical spectrum of childhood narcolepsy.

Postiglione E, Antelmi E, Pizza F, Lecendreux M, Dauvilliers Y, Plazzi G.

Sleep Med Rev. 2018 Apr;38:70-85. doi: 10.1016/j.smrv.2017.04.003. Epub 2017 May 8. Review.

PMID:
28666745
9.

Mazindol: a risk factor for pulmonary arterial hypertension?

Konofal E, Benzouid C, Delclaux C, Lecendreux M, Hussey E.

Sleep Med. 2017 Jun;34:168-169. doi: 10.1016/j.sleep.2017.02.020. Epub 2017 Mar 18. Review.

PMID:
28522087
10.

Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells.

Lecendreux M, Churlaud G, Pitoiset F, Regnault A, Tran TA, Liblau R, Klatzmann D, Rosenzwajg M.

PLoS One. 2017 Jan 20;12(1):e0169836. doi: 10.1371/journal.pone.0169836. eCollection 2017.

11.

Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study.

Lecendreux M, Berthier J, Corny J, Bourdon O, Dossier C, Delclaux C.

J Clin Sleep Med. 2017 Mar 15;13(3):441-453. doi: 10.5664/jcsm.6500.

12.

French consensus. Management of patients with hypersomnia: Which strategy?

Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y.

Rev Neurol (Paris). 2017 Jan - Feb;173(1-2):8-18. doi: 10.1016/j.neurol.2016.09.018. Epub 2016 Nov 16. Review.

PMID:
27865546
13.

Comorbidity between central disorders of hypersomnolence and immune-based disorders.

Barateau L, Lopez R, Arnulf I, Lecendreux M, Franco P, Drouot X, Leu-Semenescu S, Jaussent I, Dauvilliers Y.

Neurology. 2017 Jan 3;88(1):93-100. doi: 10.1212/WNL.0000000000003432. Epub 2016 Nov 18.

PMID:
27864522
14.

French consensus. Hypersomnolence: Evaluation and diagnosis.

Dauvilliers Y, Lopez R, Lecendreux M.

Rev Neurol (Paris). 2017 Jan - Feb;173(1-2):19-24. doi: 10.1016/j.neurol.2016.09.017. Epub 2016 Nov 9. Review.

PMID:
27838094
15.

[Narcolepsy in sleepy obese children. Two case reports].

Rives-Lange C, Karsenty A, Chantereau H, Oderda L, Dubern B, Lecendreux M, Tounian P.

Arch Pediatr. 2016 Jun;23(6):603-6. doi: 10.1016/j.arcped.2016.03.012. Epub 2016 Apr 25. French.

PMID:
27133373
16.

The European Narcolepsy Network (EU-NN) database.

Khatami R, Luca G, Baumann CR, Bassetti CL, Bruni O, Canellas F, Dauvilliers Y, Del Rio-Villegas R, Feketeova E, Ferri R, Geisler P, Högl B, Jennum P, Kornum BR, Lecendreux M, Martins-da-Silva A, Mathis J, Mayer G, Paiva T, Partinen M, Peraita-Adrados R, Plazzi G, Santamaria J, Sonka K, Riha R, Tafti M, Wierzbicka A, Young P, Lammers GJ, Overeem S; European Narcolepsy Network.

J Sleep Res. 2016 Jun;25(3):356-64. doi: 10.1111/jsr.12374. Epub 2016 Jan 26.

17.

Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity.

Tafti M, Lammers GJ, Dauvilliers Y, Overeem S, Mayer G, Nowak J, Pfister C, Dubois V, Eliaou JF, Eberhard HP, Liblau R, Wierzbicka A, Geisler P, Bassetti CL, Mathis J, Lecendreux M, Khatami R, Heinzer R, Haba-Rubio J, Feketeova E, Baumann CR, Kutalik Z, Tiercy JM.

Sleep. 2016 Mar 1;39(3):581-7. doi: 10.5665/sleep.5532.

18.

A 4-year follow-up of attention-deficit/hyperactivity disorder in a population sample.

Lecendreux M, Konofal E, Cortese S, Faraone SV.

J Clin Psychiatry. 2015 Jun;76(6):712-9. doi: 10.4088/JCP.14m09555.

PMID:
26132672
19.

Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Pediatric Narcolepsy: A Cross-Sectional Study.

Lecendreux M, Lavault S, Lopez R, Inocente CO, Konofal E, Cortese S, Franco P, Arnulf I, Dauvilliers Y.

Sleep. 2015 Aug 1;38(8):1285-95. doi: 10.5665/sleep.4910.

20.

Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ?

Lecendreux M, Libri V, Jaussent I, Mottez E, Lopez R, Lavault S, Regnault A, Arnulf I, Dauvilliers Y.

J Autoimmun. 2015 Jun;60:20-31. doi: 10.1016/j.jaut.2015.03.003. Epub 2015 Apr 16.

PMID:
25892508
21.

Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes.

Lavault S, Golmard JL, Groos E, Brion A, Dauvilliers Y, Lecendreux M, Franco P, Arnulf I.

Ann Neurol. 2015 Mar;77(3):529-40. doi: 10.1002/ana.24350. Epub 2015 Feb 4.

PMID:
25559212
22.

Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder.

Konofal E, Zhao W, Laouénan C, Lecendreux M, Kaguelidou F, Benadjaoud L, Mentré F, Jacqz-Aigrain E.

Drug Des Devel Ther. 2014 Dec 1;8:2321-32. doi: 10.2147/DDDT.S65495. eCollection 2014.

23.

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial.

Coghill DR, Banaschewski T, Lecendreux M, Soutullo C, Zuddas A, Adeyi B, Sorooshian S.

Neuropsychiatr Dis Treat. 2014 Oct 29;10:2039-47. doi: 10.2147/NDT.S68273. eCollection 2014.

24.

Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.

Banaschewski T, Johnson M, Lecendreux M, Zuddas A, Adeyi B, Hodgkins P, Squires LA, Coghill DR.

CNS Drugs. 2014 Dec;28(12):1191-203. doi: 10.1007/s40263-014-0193-z.

25.

Pharmacological management of narcolepsy and cataplexy in pediatric patients.

Lecendreux M.

Paediatr Drugs. 2014 Oct;16(5):363-72. doi: 10.1007/s40272-014-0083-3. Review.

PMID:
25074415
26.

Quality of life in children with narcolepsy.

Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, Gerard D, Dauvilliers Y, Reimão R, Bat-Pitault F, Lin JS, Arnulf I, Lecendreux M, Franco P.

CNS Neurosci Ther. 2014 Aug;20(8):763-71. doi: 10.1111/cns.12291. Epub 2014 Jun 12.

PMID:
24922610
27.

Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design.

Coghill DR, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson CS, Civil R, Dauphin M, Higgins N, Lyne A, Gasior M, Squires LA.

J Am Acad Child Adolesc Psychiatry. 2014 Jun;53(6):647-657.e1. doi: 10.1016/j.jaac.2014.01.017. Epub 2014 Mar 4.

28.

Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies.

Stevenson J, Buitelaar J, Cortese S, Ferrin M, Konofal E, Lecendreux M, Simonoff E, Wong IC, Sonuga-Barke E.

J Child Psychol Psychiatry. 2014 May;55(5):416-27. doi: 10.1111/jcpp.12215. Epub 2014 Feb 19. Review.

PMID:
24552603
29.

Depressive feelings in children with narcolepsy.

Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, Gerard D, Dauvilliers Y, Reimão R, Bat-Pitault F, Lin JS, Arnulf I, Lecendreux M, Franco P.

Sleep Med. 2014 Mar;15(3):309-14. doi: 10.1016/j.sleep.2013.08.798. Epub 2014 Jan 8.

PMID:
24503472
30.

Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study.

Dauvilliers Y, Jaussent I, Lecendreux M, Scholz S, Bayard S, Cristol JP, Blain H, Dupuy AM.

Brain Behav Immun. 2014 Mar;37:260-6. doi: 10.1016/j.bbi.2013.12.019. Epub 2014 Jan 3.

PMID:
24394344
31.

DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.

Tafti M, Hor H, Dauvilliers Y, Lammers GJ, Overeem S, Mayer G, Javidi S, Iranzo A, Santamaria J, Peraita-Adrados R, Vicario JL, Arnulf I, Plazzi G, Bayard S, Poli F, Pizza F, Geisler P, Wierzbicka A, Bassetti CL, Mathis J, Lecendreux M, Donjacour CE, van der Heide A, Heinzer R, Haba-Rubio J, Feketeova E, Högl B, Frauscher B, Benetó A, Khatami R, Cañellas F, Pfister C, Scholz S, Billiard M, Baumann CR, Ercilla G, Verduijn W, Claas FH, Dubois V, Nowak J, Eberhard HP, Pradervand S, Hor CN, Testi M, Tiercy JM, Kutalik Z.

Sleep. 2014 Jan 1;37(1):19-25. doi: 10.5665/sleep.3300.

32.

Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder.

Banaschewski T, Soutullo C, Lecendreux M, Johnson M, Zuddas A, Hodgkins P, Adeyi B, Squires LA, Coghill D.

CNS Drugs. 2013 Oct;27(10):829-40. doi: 10.1007/s40263-013-0095-5.

33.

Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.

Dauvilliers Y, Arnulf I, Lecendreux M, Monaca Charley C, Franco P, Drouot X, d'Ortho MP, Launois S, Lignot S, Bourgin P, Nogues B, Rey M, Bayard S, Scholz S, Lavault S, Tubert-Bitter P, Saussier C, Pariente A; Narcoflu-VF study group.

Brain. 2013 Aug;136(Pt 8):2486-96. doi: 10.1093/brain/awt187.

PMID:
23884811
34.

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Soutullo C, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Bloomfield R, Squires LA, Coghill DR.

CNS Drugs. 2013 Sep;27(9):743-51. doi: 10.1007/s40263-013-0086-6.

35.

Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial.

Coghill DR, Banaschewski T, Lecendreux M, Zuddas A, Dittmann RW, Otero IH, Civil R, Bloomfield R, Squires LA.

Eur Child Adolesc Psychiatry. 2014 Feb;23(2):61-8. doi: 10.1007/s00787-013-0421-y. Epub 2013 May 25.

36.

Impact of obesity in children with narcolepsy.

Inocente CO, Lavault S, Lecendreux M, Dauvilliers Y, Reimao R, Gustin MP, Castets S, Spiegel K, Lin JS, Arnulf I, Franco P.

CNS Neurosci Ther. 2013 Jul;19(7):521-8. doi: 10.1111/cns.12105. Epub 2013 Apr 10.

PMID:
23574649
37.

Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study.

Luca G, Haba-Rubio J, Dauvilliers Y, Lammers GJ, Overeem S, Donjacour CE, Mayer G, Javidi S, Iranzo A, Santamaria J, Peraita-Adrados R, Hor H, Kutalik Z, Plazzi G, Poli F, Pizza F, Arnulf I, Lecendreux M, Bassetti C, Mathis J, Heinzer R, Jennum P, Knudsen S, Geisler P, Wierzbicka A, Feketeova E, Pfister C, Khatami R, Baumann C, Tafti M; European Narcolepsy Network.

J Sleep Res. 2013 Oct;22(5):482-95. doi: 10.1111/jsr.12044. Epub 2013 Mar 18.

38.

ImmunoChip study implicates antigen presentation to T cells in narcolepsy.

Faraco J, Lin L, Kornum BR, Kenny EE, Trynka G, Einen M, Rico TJ, Lichtner P, Dauvilliers Y, Arnulf I, Lecendreux M, Javidi S, Geisler P, Mayer G, Pizza F, Poli F, Plazzi G, Overeem S, Lammers GJ, Kemlink D, Sonka K, Nevsimalova S, Rouleau G, Desautels A, Montplaisir J, Frauscher B, Ehrmann L, Högl B, Jennum P, Bourgin P, Peraita-Adrados R, Iranzo A, Bassetti C, Chen WM, Concannon P, Thompson SD, Damotte V, Fontaine B, Breban M, Gieger C, Klopp N, Deloukas P, Wijmenga C, Hallmayer J, Onengut-Gumuscu S, Rich SS, Winkelmann J, Mignot E.

PLoS Genet. 2013;9(2):e1003270. doi: 10.1371/journal.pgen.1003270. Epub 2013 Feb 14.

39.

Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.

Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Döpfner M, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong IC, Sergeant J; European ADHD Guidelines Group.

Am J Psychiatry. 2013 Mar;170(3):275-89. doi: 10.1176/appi.ajp.2012.12070991. Review.

PMID:
23360949
40.

European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.

Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Lyne A, Squires L.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1208-18. doi: 10.1016/j.euroneuro.2012.11.012. Epub 2013 Jan 15.

41.

Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation.

Poli F, Overeem S, Lammers GJ, Plazzi G, Lecendreux M, Bassetti CL, Dauvilliers Y, Keene D, Khatami R, Li Y, Mayer G, Nohynek H, Pahud B, Paiva T, Partinen M, Scammell TE, Shimabukuro T, Sturkenboom M, van Dinther K, Wiznitzer M, Bonhoeffer J.

Vaccine. 2013 Jan 30;31(6):994-1007. doi: 10.1016/j.vaccine.2012.12.014. Epub 2012 Dec 16. Review. No abstract available.

PMID:
23246545
42.

Iron and attention deficit/hyperactivity disorder: What is the empirical evidence so far? A systematic review of the literature.

Cortese S, Angriman M, Lecendreux M, Konofal E.

Expert Rev Neurother. 2012 Oct;12(10):1227-40. doi: 10.1586/ern.12.116. Review.

PMID:
23082739
43.

Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.

Nittur N, Konofal E, Dauvilliers Y, Franco P, Leu-Semenescu S, Cock VC, Inocente CO, Bayard S, Scholtz S, Lecendreux M, Arnulf I.

Sleep Med. 2013 Jan;14(1):30-6. doi: 10.1016/j.sleep.2012.07.008. Epub 2012 Oct 1.

PMID:
23036267
44.

Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study.

Lecendreux M, Poli F, Oudiette D, Benazzouz F, Donjacour CE, Franceschini C, Finotti E, Pizza F, Bruni O, Plazzi G.

Sleep. 2012 May 1;35(5):709-11. doi: 10.5665/sleep.1836.

45.

Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy.

Lecendreux M, Bruni O, Franco P, Gringras P, Konofal E, Nevsimalova S, Paiva T, Partinen M, Peeters E, Peraita-Adrados R, Plazzi G, Poli F.

J Sleep Res. 2012 Aug;21(4):481-3. doi: 10.1111/j.1365-2869.2011.00991.x. Epub 2012 Jan 28. No abstract available.

46.

Growth dysregulation and ADHD: an epidemiologic study of children in France.

Faraone SV, Lecendreux M, Konofal E.

J Atten Disord. 2012 Oct;16(7):572-8. doi: 10.1177/1087054711413083. Epub 2011 Aug 4.

PMID:
21817155
47.

[Evaluation of excessive daytime sleepiness in child and adolescent psychopathology].

Carrot B, Lecendreux M.

Arch Pediatr. 2011 Aug;18(8):891-901. doi: 10.1016/j.arcped.2011.05.012. Epub 2011 Jun 15. French.

PMID:
21680163
48.

Brain iron levels in attention-deficit/hyperactivity disorder: a pilot MRI study.

Cortese S, Azoulay R, Castellanos FX, Chalard F, Lecendreux M, Chechin D, Delorme R, Sebag G, Sbarbati A, Mouren MC, Bernardina BD, Konofal E.

World J Biol Psychiatry. 2012 Mar;13(3):223-31. doi: 10.3109/15622975.2011.570376. Epub 2011 May 17.

PMID:
21585274
49.

Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.

Lavault S, Dauvilliers Y, Drouot X, Leu-Semenescu S, Golmard JL, Lecendreux M, Franco P, Arnulf I.

Sleep Med. 2011 Jun;12(6):550-6. doi: 10.1016/j.sleep.2011.03.010. Epub 2011 May 14.

PMID:
21576035
50.

European guidelines on managing adverse effects of medication for ADHD.

Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E; European Guidelines Group.

Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37. doi: 10.1007/s00787-010-0140-6. Epub 2010 Nov 3.

Supplemental Content

Loading ...
Support Center